Evan Do

Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection

Rachel E. Brewer, I. Weissman, A. Gingras, 2021, medRxiv.

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Garry P. Nolan, N. Aghaeepour, D. Gaudillière, 2022, Cell reports. Medicine.

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Garry P. Nolan, N. Aghaeepour, D. Gaudillière, 2022, Cell reports. Medicine.

Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome

H. Din, K. Nadeau, H. Maecker, 2022, JCI insight.

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

G. Nolan, N. Aghaeepour, D. Gaudillière, 2021, bioRxiv.

New-onset IgG autoantibodies in hospitalized patients with COVID-19

E. Wherry, K. Nadeau, W. Robinson, 2021, Nature Communications.

CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy

R. Tibshirani, K. Nadeau, M. Tsai, 2022, Nature Communications.

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Paul J. Hung, Aaron J. Wilk, E. Ashley, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System

C. Akdis, K. Nadeau, M. Tsai, 2021, JAMA network open.

Disrupted epithelial permeability as a predictor of severe COVID‐19 development

C. Akdis, K. Nadeau, M. Akdiş, 2023, Allergy.

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

E. Wherry, K. Nadeau, M. Radic, 2021, medRxiv.